Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications
Beyond Bedside Implementation: Why Procurement and Vendor Management Matter for Sustainable AI.
Journal: Nursing & health sciences
Published: June 23, 2026
Cytogenetic and Molecular Analysis of a "Double-Hit" RUNX1 Including a RUNX1 p.Trp279* and a Cryptic Novel t(6;21)(q25;q22)/RUNX1::ARID1B in Acute Myeloid Leukemia.
Journal: Genes, chromosomes & cancer
Published: February 18, 2026
A commentary on "CT-based radiomics signature of visceral adipose tissue for prediction of early recurrence in patients with NMIBC: a multicentre cohort study".
Journal: International journal of surgery (London, England)
Published: January 24, 2026
Long-term survival with tocilizumab treatment for tislelizumab-related pneumonitis in a patient with non-small cell lung cancer: A case report.
Journal: Oncology letters
Published: August 06, 2025
Stereotactic Radiosurgery in Multidisciplinary Management of HER2-Positive Gastroesophageal Junction Adenocarcinoma with Large-Brain Metastases: A 9-Year Survival Case.
Journal: Cancer management and research
Published: July 23, 2025
Denosumab Combined With PARP Inhibitors and Chemoradiotherapy for Treating Triple Negative Breast Cancer With Bone Metastasis: A Case Report.
Journal: Cancer reports (Hoboken, N.J.)
Published: March 06, 2025
The concomitant of non-classical stereotactic body radiotherapy with tislelizumab based on multidisciplinary modalities for leiomyosarcoma: A case report.
Journal: Medicine
Published: November 13, 2024
Dual inhibition of ATR and DNA-PKcs radiosensitizes ATM-mutant prostate cancer.
Journal: bioRxiv : the preprint server for biology
Published: July 19, 2024
Dual inhibition of ATR and DNA-PKcs radiosensitizes ATM-mutant prostate cancer.
Journal: Oncogene
Published: July 11, 2024
Nuclear DAB2IP regulates DNA replication initiation through activating PLK1-mediated HBO1 phosphorylation.
Journal: Nucleic acids research
Published: July 01, 2024
The safety, pharmacokinetics and neutralizing activity of recombinant human anti-rabies monoclonal antibody NM57 injection (rhRIG, Ormutivimab) in combination with rabies vaccination in Chinese healthy adults: A phase Ib randomized, double-blind, parallel-controlled clinical study.
Journal: Travel medicine and infectious disease
Published: April 08, 2024
Last Updated: 09/26/2026